A Las Vegas area affiliate of R3 Stem Cell, a network of regenerative medicine centres offering donor umbilical cord and amniotic fluid cell treatments for a wide range of conditions.
This listing is for the Las Vegas affiliate of R3 Stem Cell, a network that describes itself as operating more than 80 centres in eight countries. The page is part of the network's own site rather than a clinic's independent website, and the information it publishes is largely about the network and its products rather than about this particular Nevada location.
The treatments described are donor-derived, which distinguishes this provider from the Las Vegas clinics that inject the patient's own blood, bone marrow or fat. The network states that it uses stem cells only from umbilical cords and amniotic fluid, and describes source material taken from the placenta, placental membrane, umbilical cord tissue, umbilical cord blood and the cord substance known as Wharton's jelly. It states that donors are healthy, consenting women under 35 undergoing a planned caesarean section, and that tissue which would normally be discarded is used. Exosome therapy, platelet rich plasma (PRP, prepared from the patient's own blood), a proprietary plasma preparation, and bone marrow and fat derived cells are also listed.
Two claims need careful reading. The network states that these products are handled as Section 361 human tissue products under the federal regulations at 21 CFR Part 1271, and that such products do not require Food and Drug Administration licensing or approval. Its own disclaimer also states that stem cell therapy is experimental and is not approved by that agency. Those two statements sit together, and a prospective patient should understand that the second one applies: what is on offer is not an approved treatment.
The list of conditions the network associates with treatment is very broad, extending from arthritis and back pain to multiple sclerosis, Parkinson's disease, spinal cord injury, heart disease and diabetes. For most of those, cell therapy is not an established treatment and the evidence is limited or absent. No physician is named for the Las Vegas location on the pages reviewed, no street address is published, and free initial consultations are offered, but no prices.
The network associates treatment with a very wide range of conditions, most of which are not established indications for cell therapy.
Unlike most Las Vegas providers, this network's main products are donor-derived birth tissue preparations rather than the patient's own tissue, and it sets out the source material in some detail.
No clinician is identified for this location.
The page is part of a network website and does not describe premises. It refers to a Henderson location without giving a street address, and no clinic photographs, treatment room description, accreditation or imaging detail is published. There is no information about where the donor tissue products are stored or who supplies them to the local clinic. A prospective patient would be relying entirely on a telephone conversation to establish where treatment would take place and under what conditions, which is a material gap for a provider offering donor tissue injections.
The site publishes no prices or price ranges for umbilical cord, amniotic fluid, exosome or platelet treatments. It offers a free initial consultation, at which costs would be discussed. Because the network's own disclaimer describes stem cell therapy as experimental and not approved by the Food and Drug Administration, treatment would be paid for privately rather than by insurance, so the total cost of any recommended course is the figure to ask for.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.